West China Hospital: Squamous Cell Carcinoma of Head and Neck trials

The registry lists 17 Squamous Cell Carcinoma of Head and Neck studies with West China Hospital as lead sponsor. 7 are open to participants now and 0 have results posted.

Phase 1 8Phase 2 10No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Online Sharing for Head & Neck Cancer SupportRecruitingNCT07766226Not applicable
• Neoadjuvant ICI and Mitochondrial Vaccine for Resectable HNSCCRecruitingNCT07572864Phase 2
• Clinical Study of CFH Protein Via Ice Microneedles for Radiation-Induced Skin FibrosisRecruitingNCT07567235Phase 1
• H101 Plus TACE for r/m HNSCCRecruitingNCT07398664Phase 2
• A Phase II Clinical Trial of Anti-EGFR Antibody-drug Conjugate (ADC) Combined With or Without Immune Checkpoint Inhibitors in the Neoadjuvant Treatment of Resectable Locally Advanced Head and Neck Squamous Cell CarcinomaRecruitingNCT07381075Phase 2
• A Study of GV20-0251 in Advanced or Refractory Solid TumorsRecruitingNCT07106827Phase 1
• DCSZ11 in Combination With Standard Therapy in Advanced or Metastatic Solid TumorsRecruitingNCT07035249Phase 1/2
• Digital Phenotyping of Psychological Distress in Skin Cancer PatientsWithdrawnNCT07670403
• A Clinical Trial Comparing Low-Dose RT + Targeted Therapy+ Immunotherapy vs Targeted Therapy+ Immunotherapy Alone as Neoadjuvant Therapy in Operable HNSCC Patients.CompletedNCT07040956Phase 2
• A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resectable Head and Neck Squamous Cell CarcinomaActive, not recruitingNCT07010120Phase 1/2
• A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted Therapy and Lysogenic HSV VirusWithdrawnNCT06741982Phase 1
• AK117 (Anti-CD47 mAb) Plus Cetuximab as Second-Line Therapy in Recurrent/Metastatic Head and Neck Squamous Cell CarcinomaCompletedNCT06508606Phase 2
• A Lithium-containing Mouthwash Prevention and Treatment of Oral Mucositis and Dysgeusia in Patients Undergoing RadiotherapyCompletedNCT06251050Phase 1/2
• Neoadjuvant Camrelizumab With Dalpiciclib for Resectable Head and Neck Squamous Cell CarcinomasStatus unknownNCT06109207Phase 1
• Streptococcus Salivarius K12 for Prevention and Treatment of Oral Mucositis in Patients Undergoing RadiotherapyCompletedNCT05918224Phase 2
• Neoadjuvant Chemotherapy, Tislelizumab With Afatinib for HNSCCCompletedNCT05516589Phase 2
• BH4 in the Prevention and Treatment of Radiation-induced Skin Reactions for Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)Status unknownNCT05299203Phase 1